Share of Clicks for top 10 US Pharma & Biotech Infectious Diseases brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| paxlovid.com | 19.02 |
| uqora.com | 12.85 |
| mavyret.com | 11.6 |
| admired.com | 6.92 |
| cabenuva.com | 5.76 |
| goodrx.com | 5.7 |
| hellowisp.com | 4.51 |
| gofreddie.com | 3.96 |
| prevnar20.com | 3.88 |
| mayoclinic.org | 2.18 |
| others | 23.62 |
- paxlovid.com - 19.02%
- uqora.com - 12.85%
- mavyret.com - 11.6%
- admired.com - 6.92%
- cabenuva.com - 5.76%
- goodrx.com - 5.7%
- hellowisp.com - 4.51%
- gofreddie.com - 3.96%
- prevnar20.com - 3.88%
- mayoclinic.org - 2.18%
- others - 23.62%
Copyright © Adthena. All rights reserved.
In the PPC landscape, paxlovid.com leads with 19.02% click share, closely followed by uqora.com at 12.85%. Meanwhile, ‘others’ collectively hold a significant 23.62%, showcasing diverse competition.
Share of Spend for the top 10 US Pharma & Biotech Infectious Diseases brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | mavyret.com | cabenuva.com | gofreddie.com | uqora.com | goodrx.com | dovato.com | admired.com | prevnar20.com | paxlovid.com | hellowisp.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/05/01 | 7.39% | 12.5% | 4.29% | 15.05% | 2.93% | 4.11% | 13.86% | 6.2% | 5.19% | 2.9% |
| 2026/05/02 | 6.51% | 17.75% | 4.14% | 8.04% | 6.82% | 3.36% | 9.18% | 6.35% | 3.9% | 2.78% |
| 2026/05/03 | 16.04% | 18.52% | 4.03% | 1.66% | 11.58% | 4.9% | 0% | 6.1% | 5.72% | 1.93% |
| 2026/05/04 | 11.13% | 15.24% | 5.15% | 10.85% | 5.55% | 1.73% | 6.32% | 5.43% | 5.12% | 0% |
| 2026/05/05 | 9.66% | 11.53% | 2.4% | 10.15% | 4.39% | 4.72% | 9.76% | 4.63% | 4.47% | 6.6% |
| 2026/05/06 | 8.27% | 9.64% | 4.09% | 11.79% | 2.96% | 7.52% | 10.07% | 5.45% | 5.63% | 0.85% |
| 2026/05/07 | 8.52% | 11.44% | 3.68% | 15.29% | 5.45% | 3.96% | 12.72% | 4.24% | 4.03% | 5.06% |
| 2026/05/08 | 6.87% | 9.77% | 4.44% | 10.1% | 7.92% | 7.25% | 9.53% | 5.27% | 5.64% | 5.76% |
| 2026/05/09 | 6.49% | 13.35% | 4.19% | 12.22% | 6.35% | 4.99% | 10.44% | 3.59% | 5.26% | 6.36% |
| 2026/05/10 | 11.34% | 18.65% | 4.61% | 6.93% | 2.43% | 8.14% | 4.74% | 4.02% | 5.15% | 2.02% |
| 2026/05/11 | 11.76% | 11.52% | 5.12% | 5.58% | 5.16% | 8.05% | 3.92% | 4.94% | 5.53% | 1.68% |
| 2026/05/12 | 8.16% | 12.44% | 4.57% | 16.21% | 6.41% | 2.71% | 9.95% | 3.99% | 4.99% | 2.92% |
| 2026/05/13 | 5.42% | 15.85% | 5.39% | 15.39% | 0% | 8.09% | 3.29% | 6.16% | 7.26% | 0.05% |
| 2026/05/14 | 11.32% | 14.96% | 7.17% | 12.82% | 0% | 4.62% | 3.04% | 4.16% | 4.63% | 0.03% |
| 2026/05/15 | 6.87% | 9.76% | 4.44% | 10.09% | 7.92% | 7.24% | 9.52% | 5.27% | 5.63% | 5.76% |
| 2026/05/16 | 7.12% | 13.58% | 7.38% | 16.52% | 0.99% | 8.02% | 2.47% | 4.55% | 5.19% | 6.78% |
| 2026/05/17 | 7.28% | 13.63% | 5.87% | 14.74% | 1.83% | 4.47% | 8.72% | 5.08% | 3.79% | 5.59% |
| 2026/05/18 | 7.63% | 14.85% | 8.85% | 7.45% | 1.54% | 9.33% | 5.09% | 7.07% | 5.44% | 4.48% |
| 2026/05/19 | 5.56% | 11.6% | 3.83% | 19.31% | 2.29% | 3.72% | 14.49% | 5.27% | 4.86% | 5.49% |
| 2026/05/20 | 6.41% | 5.74% | 6.96% | 25.27% | 0.9% | 4.26% | 13.51% | 4.02% | 3.87% | 5.39% |
| 2026/05/21 | 11.39% | 11.67% | 6.56% | 9.15% | 2.5% | 3.52% | 8.86% | 5.01% | 6.2% | 3.89% |
| 2026/05/22 | 16.02% | 8.71% | 6.73% | 18.51% | 0.15% | 7.38% | 0% | 4.4% | 6.59% | 0% |
| 2026/05/23 | 14.12% | 7.5% | 5.99% | 15.9% | 0.04% | 9.25% | 3.14% | 4.34% | 5.49% | 0% |
| 2026/05/24 | 13.6% | 12.85% | 8.71% | 11.42% | 1.29% | 5.53% | 9.76% | 4.24% | 4.42% | 3.34% |
| 2026/05/25 | 9.52% | 11.3% | 4.43% | 17.75% | 2% | 8.28% | 3.63% | 4.17% | 3.43% | 2.5% |
| 2026/05/26 | 17.63% | 9.6% | 8.97% | 8.24% | 2.95% | 4.66% | 5.1% | 3.8% | 4.71% | 2.07% |
| 2026/05/27 | 16.94% | 12.06% | 4.98% | 2.57% | 4.48% | 8.7% | 5.49% | 5.11% | 4.94% | 0.75% |
| 2026/05/28 | 12.19% | 9% | 3.84% | 10.3% | 6.52% | 4.69% | 10.44% | 3.53% | 4.02% | 4.41% |
| 2026/05/29 | 16.89% | 10.11% | 3.7% | 6.21% | 7.16% | 3.51% | 6.39% | 3.65% | 4.23% | 4.88% |
| 2026/05/30 | 12.59% | 11.46% | 6.3% | 6.51% | 4.87% | 6.38% | 6.43% | 4.38% | 4.7% | 3.84% |
| 2026/05/31 | 14.26% | 10.59% | 10% | 7.21% | 6.51% | 5.49% | 4.11% | 3.93% | 2.98% | 0.75% |
- mavyret.com
- cabenuva.com
- gofreddie.com
- uqora.com
- goodrx.com
- dovato.com
- admired.com
- prevnar20.com
- paxlovid.com
- hellowisp.com
Copyright © Adthena. All rights reserved.
In May 2026, mavyret.com saw fluctuating PPC spend, peaking mid-month. Cabenuva.com maintained a strong presence, while gofreddie.com and uqora.com showed varied trends. The month concluded with diverse advertiser strategies.
Competitor Count for US Pharma & Biotech Infectious Diseases
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/05/01 | 66 |
| 2026/05/02 | 62 |
| 2026/05/03 | 64 |
| 2026/05/04 | 68 |
| 2026/05/05 | 71 |
| 2026/05/06 | 68 |
| 2026/05/07 | 74 |
| 2026/05/08 | 72 |
| 2026/05/09 | 71 |
| 2026/05/10 | 73 |
| 2026/05/11 | 74 |
| 2026/05/12 | 74 |
| 2026/05/13 | 73 |
| 2026/05/14 | 77 |
| 2026/05/15 | 72 |
| 2026/05/16 | 76 |
| 2026/05/17 | 75 |
| 2026/05/18 | 75 |
| 2026/05/19 | 73 |
| 2026/05/20 | 72 |
| 2026/05/21 | 69 |
| 2026/05/22 | 69 |
| 2026/05/23 | 71 |
| 2026/05/24 | 71 |
| 2026/05/25 | 76 |
| 2026/05/26 | 73 |
| 2026/05/27 | 70 |
| 2026/05/28 | 71 |
| 2026/05/29 | 71 |
| 2026/05/30 | 69 |
| 2026/05/31 | 71 |
Copyright © Adthena. All rights reserved.
May began with 66 advertisers, fluctuating throughout the month, peaking at 77 on May 14. The month concluded with 71 advertisers, reflecting a dynamic landscape.
